Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $8.51 billion. The enterprise value is $8.39 billion.
| Market Cap | 8.51B |
| Enterprise Value | 8.39B |
Important Dates
The last earnings date was Wednesday, April 24, 2024, after market close.
| Earnings Date | Apr 24, 2024 |
| Ex-Dividend Date | Feb 23, 2024 |
Share Statistics
Chemed has 15.14 million shares outstanding. The number of shares has increased by 1.52% in one year.
| Shares Outstanding | 15.14M |
| Shares Change (YoY) | +1.52% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 2.19% |
| Owned by Institutions (%) | 97.35% |
| Float | 14.81M |
Valuation Ratios
The trailing PE ratio is 30.42 and the forward PE ratio is 23.75. Chemed's PEG ratio is 2.63.
| PE Ratio | 30.42 |
| Forward PE | 23.75 |
| PS Ratio | 3.73 |
| Forward PS | 3.44 |
| PB Ratio | 7.23 |
| P/FCF Ratio | 28.26 |
| PEG Ratio | 2.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 19.63, with an EV/FCF ratio of 27.71.
| EV / Earnings | 29.62 |
| EV / Sales | 3.66 |
| EV / EBITDA | 19.63 |
| EV / EBIT | 22.96 |
| EV / FCF | 27.71 |
Financial Position
The company has a current ratio of 1.91, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.91 |
| Quick Ratio | 1.74 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.34 |
| Debt / FCF | 0.48 |
| Interest Coverage | 184.49 |
Financial Efficiency
Return on equity (ROE) is 26.60% and return on invested capital (ROIC) is 19.93%.
| Return on Equity (ROE) | 26.60% |
| Return on Assets (ROA) | 17.50% |
| Return on Capital (ROIC) | 19.93% |
| Revenue Per Employee | $152,018 |
| Profits Per Employee | $18,785 |
| Employee Count | 15,087 |
| Asset Turnover | 1.42 |
| Inventory Turnover | 138.48 |
Taxes
In the past 12 months, Chemed has paid $80.28 million in taxes.
| Income Tax | 80.28M |
| Effective Tax Rate | 22.07% |
Stock Price Statistics
The stock price has increased by +4.65% in the last 52 weeks. The beta is 0.46, so Chemed's price volatility has been lower than the market average.
| Beta (1Y) | 0.46 |
| 52-Week Price Change | +4.65% |
| 50-Day Moving Average | 609.82 |
| 200-Day Moving Average | 570.08 |
| Relative Strength Index (RSI) | 35.90 |
| Average Volume (30 Days) | 80,835 |
Short Selling Information
The latest short interest is 297,126, so 1.96% of the outstanding shares have been sold short.
| Short Interest | 297,126 |
| Short Previous Month | 451,553 |
| Short % of Shares Out | 1.96% |
| Short % of Float | 2.01% |
| Short Ratio (days to cover) | 3.88 |
Income Statement
In the last 12 months, Chemed had revenue of $2.29 billion and earned $283.41 million in profits. Earnings per share was $18.59.
| Revenue | 2.29B |
| Gross Profit | 813.47M |
| Operating Income | 340.08M |
| Pretax Income | 363.69M |
| Net Income | 283.41M |
| EBITDA | 427.54M |
| EBIT | 365.67M |
| Earnings Per Share (EPS) | $18.59 |
Balance Sheet
The company has $313.35 million in cash and $146.14 million in debt, giving a net cash position of $167.21 million or $11.04 per share.
| Cash & Cash Equivalents | 313.35M |
| Total Debt | 146.14M |
| Net Cash | 167.21M |
| Net Cash Per Share | $11.04 |
| Equity / Book Value | 1.18B |
| Book Value Per Share | 78.17 |
| Working Capital | 257.64M |
Cash Flow
In the last 12 months, operating cash flow was $354.36 million and capital expenditures -$51.42 million, giving a free cash flow of $302.94 million.
| Operating Cash Flow | 354.36M |
| Capital Expenditures | -51.42M |
| Free Cash Flow | 302.94M |
| FCF Per Share | $20.03 |
Margins
Gross margin is 35.47%, with operating and profit margins of 14.83% and 12.36%.
| Gross Margin | 35.47% |
| Operating Margin | 14.83% |
| Pretax Margin | 15.86% |
| Profit Margin | 12.36% |
| EBITDA Margin | 18.64% |
| EBIT Margin | 15.94% |
| FCF Margin | 13.21% |
Dividends & Yields
This stock pays an annual dividend of $1.60, which amounts to a dividend yield of 0.28%.
| Dividend Per Share | $1.60 |
| Dividend Yield | 0.28% |
| Dividend Growth (YoY) | 5.33% |
| Years of Dividend Growth | 15 |
| Payout Ratio | 8.61% |
| Buyback Yield | -1.52% |
| Shareholder Yield | -1.23% |
| Earnings Yield | 3.31% |
| FCF Yield | 3.54% |
Analyst Forecast
The average price target for Chemed is $681.00, which is 20.89% higher than the current price. The consensus rating is "Buy".
| Price Target | $681.00 |
| Price Target Difference | 20.89% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 13.68 and a Piotroski F-Score of 7.
| Altman Z-Score | 13.68 |
| Piotroski F-Score | 7 |